Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy

by on 1 de juliol de 2024 with No hi ha comentaris
  • Resa-Infante, P., Erkizia, I., Muñiz-Trabudua, X., Linty, F., Bentlage, A. E. H., Perez-Zsolt, D.,…Martinez-Picado, J. (2024). Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy. Biomedicine & Pharmacotherapy, 175, Article 116726. https://doi.org/10.1016/j.biopha.2024.116726

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *